Skip to main content
Clinical Trials/NCT02311465
NCT02311465
Withdrawn
Not Applicable

A Randomized Study of Early Palliative Care Integrated With Standard Oncology Care Versus Oncology Care Alone in Patients With Non-colorectal Gastrointestinal Malignancies.

Vanderbilt University1 site in 1 countryDecember 2015
ConditionsQuality of Life

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Quality of Life
Sponsor
Vanderbilt University
Locations
1
Primary Endpoint
Functional Assessment of Cancer Therapy: General (FACT-G) Health Related Quality of Life Questionnaire
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this research study is to find out whether it is better to introduce cancer patients to the palliative care team at a later date when there is a specific issue or problem or to introduce cancer patients to the palliative care team when first diagnosed before any specific issue or problem occurs.

Detailed Description

The investigators will conduct a one-year randomized, controlled study to evaluate the impact of an early, integrated palliative care services. The intervention will include comprehensive palliative care services delivered in conjunction with standard oncology care and patient friendly materials for high risk oncology patients. The investigators primary clinical endpoint will be health related quality of life, specifically focusing on measures of anxiety, depression, and well-being. Secondary personalized palliative care outcomes are expected to include: * Reduced deviations from care plan as captured in the medical record compared to the group who did not receive early, integrated palliative care services * Reduced hospital utilization compared to the group who did not receive early, integrated palliative care services

Registry
clinicaltrials.gov
Start Date
December 2015
End Date
December 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gordon Bernard

Professor of Medicine; Associate Vice-Chancellor for Research

Vanderbilt University

Eligibility Criteria

Inclusion Criteria

  • -Adults with newly diagnosed pancreatic, hepatocellular, esophageal, or stomach cancer
  • Upcoming scheduled oncology clinic visit (2nd visit to the clinic) at Vanderbilt
  • Ability to read and respond to questions in English
  • Permission of oncology physician

Exclusion Criteria

  • -Receiving oncology care at non-Vanderbilt sites (to ensure appropriate follow-up)
  • Participation in another clinical trial

Outcomes

Primary Outcomes

Functional Assessment of Cancer Therapy: General (FACT-G) Health Related Quality of Life Questionnaire

Time Frame: 1 year

The FACT Measurement System is a group of questions which measure health-related quality of life (QOL) in cancer patients. The FACT-G is a 26-item version that addresses multiple QOL dimensions including physical well-being, functional well-being, emotional well-being and social well-being. The response format of the FACT Measurement System consists of a 5-point Likert scale.

Secondary Outcomes

  • PROMIS Depression Scale(1 year)
  • PROMIS Anxiety Scale(1 year)
  • Hospitalizations(1 year)

Study Sites (1)

Loading locations...

Similar Trials